Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2006-02-28
2006-02-28
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S234100, C424S256100, C424S193100, C424S831000, C424S184100, C435S091500, C536S127000, C536S123100
Reexamination Certificate
active
07005129
ABSTRACT:
A method is provided for identifying, isolating, and producing htrB mutants of gram-negative bacterial pathogens. The method comprises mutating the htrB gene of a gram-negative bacterial pathogen so that there is a lack of a functional htrB protein, resulting in a mutant that lacks one or more secondary acyl chains contained in the wild type gram-negative bacterial pathogen, and displays substantially reduced toxicity as compared to the wild type strain. Also, the present invention provides methods for using a vaccine formulation containing the htrB mutant, the endotoxin isolated therefrom, or the endotoxin isolated therefrom which is then conjugated to a carrier protein, to immunize an individual against infections caused by gram-negative bacterial pathogens by administering a prophylactically effective amount of the vaccine formulation.
REFERENCES:
patent: 4912094 (1990-03-01), Myers et al.
patent: 4929604 (1990-05-01), Munford et al.
patent: 5200184 (1993-04-01), Munford et al.
patent: 5641492 (1997-06-01), Sprouse et al.
patent: 6482807 (2002-11-01), Van Der Ley et al.
patent: 6548287 (2003-04-01), Powell et al.
patent: WO-97/18837 (1997-05-01), None
Gupta et al. Infect. Immun. 60: 3201-3208, 1992.
Karow et al. Mol. Microbiol. 5: 2285-2292, 1991.
Westphal et al. Methods in Carbohydrate Chemistry 5: 83-91, 1965.
McLaughlin et al. J. Bacteriol. 174: 6455-6459, 1992.
Karow ML. Molecular Genetics of theEscherichia colihtrB gnee. Ph.D. Dissertation, The Utah University, 1992.
Jachymek W. Post Hih. Med. Dosw. 49: 171-178, 1995.
Raetz CRH. Annu. Rev. Biochem. 59: 129-170, 1990.
Kulshin et al. J. Bacteriol. 174: 1793-1800, 1992.
Karow, M., et al., “Isolation and Characterization of theEscherichia colihtrB gene, whose product is essential for bacterial viability above 33degreesC in rich media”,Journal of Bacteriology, vol. 173, No. 2, pp. 741-750, (Jan. 1991).
Karow, M., et al., “The lethal Phenotype 'caused by null mutations in theEscherichia colihtrB gene is suppressed by Mutations in the accBC Operon, Encoding two subunits of acetyl coenzyme A carboxylase”,Journal of Bacteriology, vol. 174, No. 22, pp. 7407-7418, (Nov. 1992).
Lee, N., et al., “Mutation of the htrB locus ofHaemophilus influenzaenontypable strain 2019 is associated with modifications of lipid A and physophorylation of the lipo-oligosaccharide”,The Journal of Biological Chemistry, vol. 270, No. 45, pp. 27151-27159, (Nov. 10, 1995).
Lehmann, V., et al., “Isolation of a mutant fromSalmonella typhimuriumproducing acyl-deficient lipopolysaccharides”, 459-464, (1988).
Brooks, G.F., et al., “Enteric Gram-negative rods (enterobacteriaceae)”,Medical Microbiology, p. 206, (1995).
Lee, Na-Gyong.,et al. ,“Mutation of the htrB Locus ofHaemophilus influenzaenontypable strain 2019 is associated with modifications of Lipid A and phosphorylation of the liip-oligosaccharide”,J. of Biological Chem., 270(45), (Nov. 10, 1995), pp. 27151-27159.
Golenbock, Douglas.T. ,et al. ,“Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes”,J. of Biological Chem., 266(29), (1991), pp. 19490-19498.
Raetz, Christian.R. ,“Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction”,J. of Bacteriology,175(18), (Sep. 1993), pp. 5745-5753.
Hitchcock, P. , et al., “Morphological Heterogeneity Among Salmonella Lipopolysaccharide Chemotypes in Silver-Stained Polyacrylamide Gels”,J. of Bacteriology, vol. 154, No. 1(Apr. 1983), 269-277.
Apicella Michael A.
Arumugham Rasappa
Gibson Bradford W.
Lee Na-Gyong
Sunshine Melvin G.
Devi S.
The Regents of the University of California
University of Iowa Research Foundation
Viksnins Harris & Padys PLLP
LandOfFree
Non-toxic mutants of pathogenic gram-negative bacteria does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-toxic mutants of pathogenic gram-negative bacteria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-toxic mutants of pathogenic gram-negative bacteria will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3688179